ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION
$1,499,999N01FY2022AINIH
Hbvtech, Germantown MD
Investigators
Abstract
To support a Phase II proposal to develop a new hepatitis B virus (HBV) cure drug. The Phase II proposal seeks to expand on the development of the lead compound supported under a Phase I study.
View original record on NIH RePORTER →